Citation

Verobyev L, Grossman R, Schwartz MA. CNS Spectr. 1998; 3(2): 66-68.

Copyright

(Copyright © 1998, MBL Communications)

DOI

10.1017/s1092852900005575

PMID

unavailable

Abstract

[Abstract unavailable]

Language: en

Keywords

atenolol; chlorpromazine; clinical trial; clozapine; drug efficacy; extrapyramidal symptom; hallucination; haloperidol; human; letter; neuroleptic agent; norclozapine; olanzapine; paranoid schizophrenia; priority journal; rating scale; suicide; treatment indication; treatment planning